Literature DB >> 26286366

Trends in the Surgical Management of Crohn's Disease.

Cristina B Geltzeiler1, Kyle D Hart1, Kim C Lu1, Karen E Deveney1, Daniel O Herzig1, Vassiliki L Tsikitis2.   

Abstract

INTRODUCTION: Although medical management of Crohn's disease has changed in recent years, it is unclear whether surgical management has altered. We examined rate changes of surgical interventions, stoma constructions, and subset of ileostomy and colostomy constructions.
MATERIALS AND METHODS: We reviewed the Nationwide Inpatient Sample database from 1988 to 2011. We examined the number of Crohn's-related operations and stoma constructions, including ileostomies and colostomies; a multivariable logistic regression model was developed.
RESULTS: A total of 355,239 Crohn's-related operations were analyzed. Operations increased from 13,955 in 1988 to 17,577 in 2011, p < 0.001. Stoma construction increased from 2493 to 4283, p < 0.001. The subset of ileostomies increased from 1201 to 3169, p < 0.001 while colostomies decreased from 1351 to 1201, p = 0.05. Operation percentages resulting in stoma construction increased from 18 to 24 %, p < 0.001. Weight loss (OR 2.25, 95 % CI 1.88, 2.69) and presence of perianal fistulizing disease (OR 2.91, 95 % CI 2.31, 3.67) were most predictive for requiring stoma construction.
CONCLUSIONS: Crohn's-related surgical interventions and stoma constructions have increased. The largest predictors for stoma construction are weight loss and perianal fistulizing disease. As a result, nutrition should be optimized and the early involvement of a multidisciplinary team should be considered.

Entities:  

Keywords:  Crohn’s Disease; Crohn’s-related surgical interventions; Perianal fistulizing disease; Stoma constructions

Mesh:

Year:  2015        PMID: 26286366     DOI: 10.1007/s11605-015-2911-3

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  29 in total

Review 1.  Systematic review: has disease outcome in Crohn's disease changed during the last four decades?

Authors:  F L Wolters; M G V M Russel; R W Stockbrügger
Journal:  Aliment Pharmacol Ther       Date:  2004-09-01       Impact factor: 8.171

Review 2.  Pre-operative management is associated with low rate of post-operative morbidity in penetrating Crohn's disease.

Authors:  P Zerbib; D Koriche; S Truant; A F Bouras; G Vernier-Massouille; D Seguy; F R Pruvot; A Cortot; J F Colombel
Journal:  Aliment Pharmacol Ther       Date:  2010-05-22       Impact factor: 8.171

3.  Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark.

Authors:  Tine Jess; Lene Riis; Ida Vind; Karen Vanessa Winther; Sixten Borg; Vibeke Binder; Ebbe Langholz; Ole Østergaard Thomsen; Pia Munkholm
Journal:  Inflamm Bowel Dis       Date:  2007-04       Impact factor: 5.325

Review 4.  Preoperative infliximab use and postoperative complications in Crohn's disease: a systematic review and meta-analysis.

Authors:  Zhi-Ping Yang; Liu Hong; Qiong Wu; Kai-Chun Wu; Dai-Ming Fan
Journal:  Int J Surg       Date:  2014-01-03       Impact factor: 6.071

5.  Psychological well-being and quality of life in Crohn's disease patients with an ostomy: a preliminary investigation.

Authors:  Simon R Knowles; Jarrad Wilson; Annette Wilkinson; William Connell; Michael Salzberg; David Castle; Paul Desmond; Michael A Kamm
Journal:  J Wound Ostomy Continence Nurs       Date:  2013 Nov-Dec       Impact factor: 1.741

6.  Epidemiology and natural history of inflammatory bowel diseases.

Authors:  Jacques Cosnes; Corinne Gower-Rousseau; Philippe Seksik; Antoine Cortot
Journal:  Gastroenterology       Date:  2011-05       Impact factor: 22.682

7.  Initial surgical management of ulcerative colitis in the biologic era.

Authors:  Cristina B Geltzeiler; Kim C Lu; Brian S Diggs; Karen E Deveney; Kian Keyashian; Daniel O Herzig; Vassiliki L Tsikitis
Journal:  Dis Colon Rectum       Date:  2014-12       Impact factor: 4.585

8.  Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.

Authors:  Stephen B Hanauer; Brian G Feagan; Gary R Lichtenstein; Lloyd F Mayer; S Schreiber; Jean Frederic Colombel; Daniel Rachmilewitz; Douglas C Wolf; Allan Olson; Weihang Bao; Paul Rutgeerts
Journal:  Lancet       Date:  2002-05-04       Impact factor: 79.321

9.  Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery.

Authors:  J Cosnes; I Nion-Larmurier; L Beaugerie; P Afchain; E Tiret; J-P Gendre
Journal:  Gut       Date:  2005-02       Impact factor: 23.059

10.  Long-term follow-up of patients with Crohn's disease. Relationship between the clinical pattern and prognosis.

Authors:  R G Farmer; G Whelan; V W Fazio
Journal:  Gastroenterology       Date:  1985-06       Impact factor: 22.682

View more
  14 in total

Review 1.  Nutritional Strategies in the Management of Adult Patients with Inflammatory Bowel Disease: Dietary Considerations from Active Disease to Disease Remission.

Authors:  Douglas L Nguyen; Berkeley Limketkai; Valentina Medici; Mardeli Saire Mendoza; Lena Palmer; Matthew Bechtold
Journal:  Curr Gastroenterol Rep       Date:  2016-10

2.  Letter to the Editor: Mesenteric Lymphatic Vessel Density Is Associated with Disease Behavior and Postoperative Recurrence in Crohn's Disease.

Authors:  Lindsay K Dickerson; Simon De Freitas; Marcos E Pozo; Bashar Safar
Journal:  J Gastrointest Surg       Date:  2018-10-01       Impact factor: 3.452

Review 3.  Role of Fecal Diversion in Complex Crohn's Disease.

Authors:  John P Burke
Journal:  Clin Colon Rectal Surg       Date:  2019-07-02

4.  When should we add a diverting loop ileostomy to laparoscopic ileocolic resection for primary Crohn's disease?

Authors:  Yong Sik Yoon; Luca Stocchi; Stefan Holubar; Alexandra Aiello; Sherief Shawki; Emre Gorgun; Scott R Steele; Conor P Delaney; Tracy Hull
Journal:  Surg Endosc       Date:  2020-05-28       Impact factor: 4.584

5.  Martius' flap for recurrent perineal and rectovaginal fistulae in a patient with Crohn's disease, endometriosis and a mullerian anomaly.

Authors:  Gaetano Gallo; Alberto Realis Luc; Giuseppe Clerico; Mario Trompetto
Journal:  BMC Surg       Date:  2017-11-21       Impact factor: 2.102

6.  Surgical Rates for Crohn's Disease are Decreasing: A Population-Based Time Trend Analysis and Validation Study.

Authors:  Christopher Ma; Gordon W Moran; Eric I Benchimol; Laura E Targownik; Steven J Heitman; James N Hubbard; Cynthia H Seow; Kerri L Novak; Subrata Ghosh; Remo Panaccione; Gilaad G Kaplan
Journal:  Am J Gastroenterol       Date:  2017-10-31       Impact factor: 10.864

7.  Restoration of intestinal continuity after stoma formation for Crohn's disease in the era of biological therapy : A retrospective cohort study.

Authors:  Catharina Müller; Michael Bergmann; Anton Stift; Stanislaus Argeny; Doug Speake; Lukas Unger; Stefan Riss
Journal:  Wien Klin Wochenschr       Date:  2020-01-08       Impact factor: 1.704

8.  Hypoalbuminaemia, Not Biologic Exposure, Is Associated with Postoperative Complications in Crohn's Disease Patients Undergoing Ileocolic Resection.

Authors:  Ravi S Shah; Salam Bachour; Xue Jia; Stefan D Holubar; Tracy L Hull; Jean-Paul Achkar; Jessica Philpott; Taha Qazi; Florian Rieder; Benjamin L Cohen; Miguel D Regueiro; Amy L Lightner; Benjamin H Click
Journal:  J Crohns Colitis       Date:  2021-07-05       Impact factor: 9.071

9.  Practical strategy for optimizing the timing of anti-tumor necrosis factor-α therapy in Crohn disease: A nationwide population-based study.

Authors:  Min Seob Kwak; Jae Myung Cha; Ji Hyun Ahn; Min Kyu Chae; Sara Jeong; Hun Hee Lee
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.889

10.  Increasing newly diagnosed inflammatory bowel disease and improving prognosis in China: a 30-year retrospective study from a single centre.

Authors:  Hong Lv; Meng Jin; Huimin Zhang; Xuanfu Chen; Meixu Wu; Mingyue Guo; Runing Zhou; Zheng Wang; Hong Yang; Jiaming Qian
Journal:  BMC Gastroenterol       Date:  2020-11-12       Impact factor: 2.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.